Akari Therapeutics Plc - ADR

0.00 (0.00%)
Earnings Announcements

Akari Therapeutics Says Company Had Cash Of About $6.7 Million, Compared To Cash Of About $14.1 Million At December 31, 2020

Published: 06/29/2021 20:20 GMT
Akari Therapeutics Plc - ADR (AKTX) - Akari Therapeutics Reports Q1 2021 Financial Results and Highlights Recent Clinical Progress.
Akari Therapeutics Plc - As of March 31, 2021, Company Had Cash of About $6.7 Million, Compared to Cash of About $14.1 Million at December 31, 2020.
Akari Therapeutics Plc - Net Loss for Q1 2021 Was About $5.8 Million, As Compared to About $3.7 Million for Same Quarter Prior Year.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be $0.00

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.